EN
HI
Bal Pharma Share price
BALPHARMA
85.93
0.73 (-0.84%)NSE
BSE
Last updated on 21 Aug, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Bal Pharma share price chart
Bal Pharma Share Key Metrics
Volume
8955.00
Market Cap
136.81 CR
LTQ@LTP
203@85.93
ATP
85.91
Var Margin
25 %
Circuit Range
68.75-103.11
Delivery %
65.4 %
Value
7.69 L
ASM/GSM
No
Market Lot
1
Summary
BALPHARMA stock price is ₹85.93 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹85.51 and ₹87.90, while Bal Pharma share price 52 week high low is ₹60.00 & ₹98.85.
In terms of trading activity, BALPHARMA share price has recorded a volume of 8,955 shares. The Bal Pharma has a market cap of ₹15920872. The stock’s Average Traded Price (ATP) stands at ₹85.91, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 203 @ ₹85.93.
The Bal Pharma upper circuit limit is ₹103.11 & The Bal Pharma lower circuit limit is ₹68.75, with a Value of ₹7.69 L. The Delivery Percentage for the day is 65.4%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Bal Pharma Resistance and Support
Pivot 86.51
Resistance
First Resistance
87.88
Second Resistance
89.11
Third Resistance
90.48
Support
First Support
85.28
Second Support
83.91
Third Support
82.68
Bal Pharma Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
50.86%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0.14%
Domestic Institutional Investors
0%
Retail
49%
Others
0%
Total Promoters
MAR '24
51.23%
JUN '24
51.23%
SEP '24
50.86%
DEC '24
50.86%
Bal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Dividend |
| 2025-02-13 | Quarterly Results & Fund Raising |
| 2024-08-12 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-18 | 2025-09-18 | View More |
Bal Pharma News
Bal Pharma Ltd - 524824 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12 2026
Bal Pharma's board approved Q1 FY27 consolidated revenue of ₹88.62 cr, up 34.53% YoY, and net profit of ₹1.14 cr, up 445.65% YoY. The board also greenlit a ₹9 cr investment in a new Joint Venture in the Philippines and allotted ₹8.4 cr worth of warrants to promoter Shailesh Siroya on a preferential basis.
Aug 12 2026 18:26:15
Bal Pharma Ltd - 524824 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Bal Pharma shareholders approved the Special Resolution to issue 10 lakh warrants to the promoter on a preferential basis. The resolution passed with 99.96% of votes in favor, declared on August 10, 2026.
Aug 10 2026 16:53:38
Bal Pharma Ltd - 524824 - Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters
Bal Pharma's board of directors is scheduled to meet on August 12, 2026. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 (Q1 FY27).
Aug 05 2026 16:09:23
Bal Pharma Ltd - 524824 - Intimation Regarding Corrigendum To The Postal Ballot Notice
Bal Pharma revised the terms for its preferential issue of 10 lakh convertible warrants to promoter Shailesh Siroya. The issue price is now Rs. 84 per warrant, raising Rs. 8.40 crore, which will part-finance a new API manufacturing facility in Karnataka.
Jul 23 2026 18:25:07
Read More
Bal Pharma Management
| Name | Position |
|---|---|
| Shailesh Siroya | Managing Director |
| Himesh Virupakshaya | Whole Time Director |
Bal Pharma FAQs
The Buying Price of Bal Pharma share is 85.93 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bal Pharma shares is 19. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bal Pharma shares is 1.64. Useful to assess the stock's value relative to its book value.
To assess Bal Pharma’s valuation compare Sector P/E, P/B which are 69.06 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bal Pharma is 136.81 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bal Pharma share price is 98.85 & 60.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bal Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BALPHARMA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC